Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lars Bullinger

Showing results (171-180 of 385) with videos related to

Pageof 39
Sort By:
Experimental Hematology|August 2, 2017
The oligodendrocyte lineage transcription factor 2 (OLIG2) is epigenetically regulated in acute myeloid leukemiaArzu Yalcin, Marlon Kovarbasic, Julius Wehrle, et al.
Journal of Medical Virology|March 22, 2024
Comparable CD8<sup>+</sup> T-cell responses to SARS-CoV-2 vaccination in single-cell transcriptomics of recently allogeneic transplanted patients and healthy individualsEva Tranter, Marco Frentsch, Marie Luise Hütter-Krönke, et al.
Immunotherapy|August 30, 2019
Clinical utility of a protein-based oncopanel in patients with end-stage head and neck cancerJohannes Doescher, Stephanie E Weissinger, Stefan S Schönsteiner, et al.
Blood|May 9, 2007
Gene-expression profiling identifies distinct subclasses of core binding factor acute myeloid leukemiaLars Bullinger, Frank G Rücker, Stephan Kurz, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|January 5, 2021
B cell depletion and signs of sepsis-acquired immunodeficiency in bone marrow and spleen of COVID-19 deceasedJana Ihlow, Edward Michaelis, Selina Greuel, et al.
Trials|May 29, 2020
Core outcome set measurement for future clinical trials in acute myeloid leukemia: the HARMONY study protocol using a multi-stakeholder consensus-based Delphi process and a final consensus meetingKatharina M Lang, Kathryn L Harrison, Paula R Williamson, et al.
Haematologica|October 4, 2017
Circular RNAs of the nucleophosmin (NPM1) gene in acute myeloid leukemiaSusanne Hirsch, Tamara J Blätte, Sarah Grasedieck, et al.
Cytotherapy|May 7, 2022
Rapid single-cell identification of Epstein-Barr virus-specific T-cell receptors for cellular therapyMaría Fernanda Lammoglia Cobo, Carlotta Welters, Leonie Rosenberger, et al.
Journal for Immunotherapy of Cancer|December 22, 2022
TIGIT blockade repolarizes AML-associated TIGIT<sup>+</sup> M2 macrophages to an M1 phenotype and increases CD47-mediated phagocytosisFranziska Brauneck, Brit Fischer, Marius Witt, et al.
Haematologica|November 11, 2021
Acute myeloid leukemia: negative prognostic impact of early blast persistence can be in part overcome by a later remission prior to post-induction therapyJana Ihlow, Sophia Gross, Leonie Busack, et al.
Pageof 39

Showing results (171-180 of 385) with videos related to

Sort By:
Pageof 39
Experimental Hematology|August 2, 2017
The oligodendrocyte lineage transcription factor 2 (OLIG2) is epigenetically regulated in acute myeloid leukemiaArzu Yalcin, Marlon Kovarbasic, Julius Wehrle, et al.
Journal of Medical Virology|March 22, 2024
Comparable CD8<sup>+</sup> T-cell responses to SARS-CoV-2 vaccination in single-cell transcriptomics of recently allogeneic transplanted patients and healthy individualsEva Tranter, Marco Frentsch, Marie Luise Hütter-Krönke, et al.
Immunotherapy|August 30, 2019
Clinical utility of a protein-based oncopanel in patients with end-stage head and neck cancerJohannes Doescher, Stephanie E Weissinger, Stefan S Schönsteiner, et al.
Blood|May 9, 2007
Gene-expression profiling identifies distinct subclasses of core binding factor acute myeloid leukemiaLars Bullinger, Frank G Rücker, Stephan Kurz, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|January 5, 2021
B cell depletion and signs of sepsis-acquired immunodeficiency in bone marrow and spleen of COVID-19 deceasedJana Ihlow, Edward Michaelis, Selina Greuel, et al.
Trials|May 29, 2020
Core outcome set measurement for future clinical trials in acute myeloid leukemia: the HARMONY study protocol using a multi-stakeholder consensus-based Delphi process and a final consensus meetingKatharina M Lang, Kathryn L Harrison, Paula R Williamson, et al.
Haematologica|October 4, 2017
Circular RNAs of the nucleophosmin (NPM1) gene in acute myeloid leukemiaSusanne Hirsch, Tamara J Blätte, Sarah Grasedieck, et al.
Cytotherapy|May 7, 2022
Rapid single-cell identification of Epstein-Barr virus-specific T-cell receptors for cellular therapyMaría Fernanda Lammoglia Cobo, Carlotta Welters, Leonie Rosenberger, et al.
Journal for Immunotherapy of Cancer|December 22, 2022
TIGIT blockade repolarizes AML-associated TIGIT<sup>+</sup> M2 macrophages to an M1 phenotype and increases CD47-mediated phagocytosisFranziska Brauneck, Brit Fischer, Marius Witt, et al.
Haematologica|November 11, 2021
Acute myeloid leukemia: negative prognostic impact of early blast persistence can be in part overcome by a later remission prior to post-induction therapyJana Ihlow, Sophia Gross, Leonie Busack, et al.
Pageof 39